Calamos Wealth Management LLC Invests $10.64 Million in Synopsys, Inc. $SNPS

Calamos Wealth Management LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) in the third quarter, HoldingsChannel reports. The firm purchased 21,555 shares of the semiconductor company’s stock, valued at approximately $10,635,000.

A number of other large investors have also added to or reduced their stakes in SNPS. Independence Bank of Kentucky lifted its position in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after acquiring an additional 30 shares during the period. Princeton Global Asset Management LLC raised its stake in Synopsys by 481.8% in the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 53 shares in the last quarter. AlphaQuest LLC lifted its position in Synopsys by 423.1% during the second quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 55 shares during the period. DiNuzzo Private Wealth Inc. grew its stake in Synopsys by 266.7% during the third quarter. DiNuzzo Private Wealth Inc. now owns 77 shares of the semiconductor company’s stock worth $38,000 after buying an additional 56 shares in the last quarter. Finally, Whipplewood Advisors LLC increased its holdings in Synopsys by 203.7% in the 2nd quarter. Whipplewood Advisors LLC now owns 82 shares of the semiconductor company’s stock valued at $42,000 after buying an additional 55 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on SNPS. Mizuho cut their price target on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. The Goldman Sachs Group reduced their target price on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Piper Sandler decreased their price target on Synopsys from $630.00 to $602.00 and set an “overweight” rating on the stock in a research note on Thursday, December 11th. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and dropped their price objective for the stock from $605.00 to $560.00 in a research report on Tuesday, December 9th. Finally, Needham & Company LLC boosted their target price on Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Eleven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $562.13.

View Our Latest Research Report on Synopsys

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.62% of the stock is owned by insiders.

Synopsys Trading Down 0.9%

Shares of SNPS stock opened at $474.49 on Wednesday. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The stock’s fifty day simple moving average is $438.40 and its 200 day simple moving average is $503.48. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $90.78 billion, a P/E ratio of 59.39, a P/E/G ratio of 3.99 and a beta of 1.16.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same period last year, the firm posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, sell-side analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.